Healthcare Press

Novo Will Limit Wegovy’s China Launch to Avoid Global Disruption

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Novo Nordisk A/S will restrict initial sales of its blockbuster obesity treatment Wegovy in China, as the drugmaker grapples with how to control access to the medicine for the world’s biggest population of obese people.

Iceland’s Debut Gender Bond Sets Template for Other GovernmentsUK Mortgage Costs Could Fall For 1.

Here's how to reduce your premiumsBenefits await gig workers who come clean with CRAGaw Capital Seeks to Buy Hong Kong Buildings Stake From PartnerSuu Kyi’s Family Mansion Will Be Up for Bidding Again in AugustNew World Tells Investors It Will Try to Pay Perp Bond Next YearBeijing Becomes Last Mega China City to Ease Housing RulesEx-Trump Associate Felix Sater Loses NY Money-Laundering TrialHighest Inventory of New US Homes Since 2008 Threatens BuildingUS New-Home Sales Slump to Slowest...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in HEALTH

Health Health Latest News, Health Health Headlines